US Physicalrapy Inc (USPH)
Cash ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 41,362 | 152,825 | 31,594 | 28,567 | 32,918 |
Short-term investments | US$ in thousands | — | 2,663 | 2,858 | — | — |
Total current liabilities | US$ in thousands | 116,283 | 102,185 | 85,489 | 83,481 | 93,492 |
Cash ratio | 0.36 | 1.52 | 0.40 | 0.34 | 0.35 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($41,362K
+ $—K)
÷ $116,283K
= 0.36
The cash ratio of US Physicalrapy Inc has shown some fluctuations over the years. As of December 31, 2020, the cash ratio was 0.35, indicating that the company had $0.35 of cash and cash equivalents for every $1 of current liabilities. This ratio decreased slightly to 0.34 by December 31, 2021. However, there was a significant increase in the cash ratio to 0.40 as of December 31, 2022, suggesting an improvement in the company's liquidity position.
The most notable change occurred by December 31, 2023, when the cash ratio surged to 1.52, signaling a substantial increase in the company's ability to cover its short-term obligations with its cash reserves. This spike could be attributed to an increase in cash holdings or a reduction in current liabilities during that period.
By December 31, 2024, the cash ratio decreased slightly to 0.36, which is still higher compared to the ratios in 2020 and 2021 but lower than the peak in 2023. Overall, the trend in the cash ratio indicates varying levels of liquidity strength for US Physicalrapy Inc during the period analyzed, with notable improvements in 2022 and 2023.
Peer comparison
Dec 31, 2024